Cellular biochemistry methods for investigating protein tyrosine phosphatases

Antioxidants and Redox Signaling

Volumn 20, Issue 14, 2014, Pages 2160-2178

  Stanford, Stephanie M ^a   Ahmed, Vanessa ^b   Barrios, Amy M ^b   Bottini, Nunzio ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; MUTANT PROTEIN; PROTEIN TYROSINE PHOSPHATASE; SYNTHETIC PEPTIDE; MOLECULAR PROBE;

ANALYTIC METHOD; ASSAY; CELL GROWTH; ENZYME ACTIVITY; ENZYME SUBSTRATE; MONITORING; OXIDATION; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOCHEMISTRY; ENZYME ASSAY; ENZYME SPECIFICITY; GENETICS; HUMAN; METABOLISM; MOLECULAR PROBE; OXIDATION REDUCTION REACTION; PROCEDURES;

ANIMALS; BIOCHEMISTRY; ENZYME ASSAYS; HUMANS; MOLECULAR PROBES; OXIDATION-REDUCTION; PROTEIN TYROSINE PHOSPHATASES; SUBSTRATE SPECIFICITY;

EID: 84898618408     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5731     Document Type: Review

References (145)

1. Agazie YM and Hayman MJ. Development of an efficient "substrate- trapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates. J Biol Chem 278: 13952-13958, 2003.
2. Almo SC, Bonanno JB, Sauder JM, Emtage S, Dilorenzo TP, Malashkevich V, et al. Structural genomics of protein phosphatases. J Struct Funct Genomics 8: 121-140, 2007.
3. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, et al. Protein tyrosine phosphatases in the human genome. Cell 117: 699-711, 2004.
4. Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, et al. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol 21: 7117-7136, 2001.
5. Baba H, Masuda Y, Sueyoshi N, and Kameshita I. In-gel phosphatase assay using non-denaturing two-dimensional electrophoresis. J Biochem 152: 557-563, 2012.
6. Barrett DM, Black SM, Todor H, Schmidt-Ullrich RK, Dawson KS, and Mikkelsen RB. Inhibition of proteintyrosine phosphatases by mild oxidative stresses is dependent on S-nitrosylation. J Biol Chem 280: 14453-14461, 2005.
7. Bayley R, Yang P, Buckley C, and Young S. Measuring the specific activity of the protein tyrosine phosphatase LYP. J Immunol Methods 388: 33-39, 2013.
8. Benitez L and Allison W. The inactivation of the acyl phosphatase activity catalyzed by the sulfenic acid form of glyceraldehyde-3-phosphate dehydrogenase by dimedone and olefins. J Biol Chem 249: 6234-6243, 1974.
9. Blaskovich MA. Drug discovery and protein tyrosine phosphatases. Curr Med Chem 16: 2095-2176, 2009.
10. Bliska JB, Clemens JC, Dixon JE, and Falkow S. The Yersinia tyrosine phosphatase: specificity of a bacterial virulence determinant for phosphoproteins in the J774A.1 macrophage. J Exp Med 176: 1625-1630, 1992.
11. Bottini N, Bottini E, Gloria-Bottini F, and Mustelin T. Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms. Arch Immunol Ther Exp (Warsz) 50: 95-104, 2002.
12. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36: 337-338, 2004.
13. Boubekeur S, Boute N, Pagesy P, Zilberfarb V, Christeff N, and Issad T. A new highly efficient substrate-trapping mutant of protein tyrosine phosphatase 1B (PTP1B) reveals full autoactivation of the insulin receptor precursor. J Biol Chem 286: 19373-19380, 2011.
14. Boute N, Boubekeur S, Lacasa D, and Issad T. Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells. EMBO Rep 4: 313-319, 2003.
15. Buhrman G, Parker B, Sohn J, Rudolph J, and Mattos C. Structural mechanism of oxidative regulation of the phosphatase Cdc25B via an intramolecular disulfide bond. Biochemistry 44: 5307-5316, 2005.
16. Burgoyne J and Eaton P. A rapid approach for the detection, quantification, and discovery of novel sulfenic acid of S-nitrosothiol modified proteins using a biotin switch method. Methods Enzymol 473: 281-303, 2010.
17. Burke T, Jr. and Zhang Z-Y. Protein-tyrosine phosphatases: structure, mechanism and inhibitor discovery. Biopolymers 47: 225-241, 1998.
18. Burridge K and Nelson A. An in-gel assay for protein tyrosine phosphatase activity: detection of widespread distribution in cells and tissues. Anal Biochem 232: 56-64, 1995.
19. Caselli A, Marzocchini R, Camici G, Manao G, Moneti G, Pieraccini G, et al. The inactivation mechanism of low molecular weight phosphotyrosine-protein phosphatase by H2O2. J Biol Chem 273: 32554-32560, 1998.
20. Chagnon MJ, Wu CL, Nakazawa T, Yamamoto T, Noda M, Blanchetot C, et al. Receptor tyrosine phosphatase sigma (RPTPr) regulates p250GAP, a novel substrate that attenuates Rac signaling. Cell Signal 22: 1626-1633, 2010.
21. Chen C-Y, Willard D, and Rudolph J. Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines. Biochemistry 48: 1399-1409, 2009.
22. Chen Y-Y, Chu H-M, Pan K-T, Teng C-H, Wang D-L, Wang A, et al. Cysteine S-nitrosylation protects protein tyrosine phosphatase 1B against oxidation-induced permanent oxidation. J Biol Chem 283: 35265-35272, 2008.
23. Chiarugi P, Fiaschi T, Taddei M, Talini D, Giannoni E, Raugei G, et al. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem 276: 33478-33487, 2001.
24. Cloutier JF and Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189: 111-121, 1999.
25. Critton DA, Tortajada A, Stetson G, Peti W, and Page R. Structural basis of substrate recognition by hematopoietic tyrosine phosphatase. Biochemistry 47: 13336-13345, 2008.
26. Cromlish WA, Payette P, and Kennedy BP. Development and validation of an intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses. Biochem Pharmacol 58: 1539-1546, 1999.
27. den Hertog J, Groen A, and van der Wijk T. Redox regulation of protein-tyrosine phosphatases. Arch Biochem Biophys 434: 11-15, 2005.
28. den Hertog J, Ö stman A, and Böhmer F. Protein tyrosine phosphtases: regulatory mechanisms. FEBS J 275: 831-847, 2008.
29. Desmarais S, Friesen RW, Zamboni R, and Ramachandran C. [Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases. Biochem J 337 (Pt 2): 219-223, 1999.
30. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283: 1544-1548, 1999.
31. Flint A, Tiganis T, Barford D, and Tonks N. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci USA 94: 1680-1685, 1997.
32. Forman H, Fukuto J, and Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am J Physiol Cell Physiol 287: C246-C256, 2004.
33. Fujikawa A, Fukada M, Makioka Y, Suzuki R, Chow JP, Matsumoto M, et al. Consensus substrate sequence for protein-tyrosine phosphatase receptor type Z. J Biol Chem 286: 37137-37146, 2011.
34. Furukawa T, Itoh M, Krueger NX, Streuli M, and Saito H. Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine- phosphorylated CD3 zeta chain. Proc Natl Acad Sci USA 91: 10928-10932, 1994.
35. Garton AJ, Flint AJ, and Tonks NK. Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST. Mol Cell Biol 16: 6408-6418, 1996.
36. Ge J, Li L, and Yao SQ. A self-immobilizing and fluorogenic unnatural amino acid that mimics phosphotyrosine. Chem Commun (Camb) 47: 10939-10941, 2011.
37. Gjorloff-Wingren A, Saxena M, Han S, Wang X, Alonso A, Renedo M, et al. Subcellular localization of intracellular protein tyrosine phosphatases in T cells. Eur J Immunol 30: 2412-2421, 2000.
38. Groen A, Lemeer S, van der Wijk T, Overvoorde J, Heck A, Ostman A, et al. Differential oxidation of protein-tyrosine phosphatases. J Biol Chem 280: 10298-10304, 2005.
39. Gulerez IE and Gehring K. X-ray crystallography and NMR as tools for the study of protein tyrosine phosphatases. Methods 65: 175-183, 2013.
40. Haj FG, Verveer PJ, Squire A, Neel BG, and Bastiaens PI. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science 295: 1708-1711, 2002.
41. Haque A, Andersen J, Salmeen A, Barford D, and Tonks N. Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity. Cell 147: 185-198, 2011.
42. Harris LK, Frumm SM, and Bishop AC. A general assay for monitoring the activities of protein tyrosine phosphatases in living eukaryotic cells. Anal Biochem 435: 99-105, 2013.
43. He R, Zeng LF, He Y, Zhang S, and Zhang ZY. Small molecule tools for functional interrogation of protein tyrosine phosphatases. FEBS J 280: 731-750, 2013.
44. Hendriks WJ, Elson A, Harroch S, Pulido R, Stoker A, and den Hertog J. Protein tyrosine phosphatases in health and disease. FEBS J 280: 708-730, 2013.
45. Heneberg P. Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs. Curr Med Chem 16: 706-733, 2009.
46. Holsinger LJ, Ward K, Duffield B, Zachwieja J, and Jallal B. The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn). Oncogene 21: 7067-7076, 2002.
47. Hsu M-F and Meng T-C. Enhancement of insulin responsiveness by nitric oxide-mediated inactivation of protein-tyrosine phosphatases. J Biol Chem 285: 7919-7928, 2010.
48. Hu M, Li L, Wu H, Su Y, Yang PY, Uttamchandani M, et al. Multicolor, one-and two-photon imaging of enzymatic activities in live cells with fluorescently Quenched Activity-Based Probes (qABPs). J Am Chem Soc 133: 12009-12020, 2011.
49. Huyer G, Liu S, Kelly J, Moffat J, Payette P, Kennedy B, et al. Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem 272: 843-851, 1997.
50. Jaffrey S and Snyder S. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001: p11, 2001.
51. Jänne P, Gray N, and Settleman J. Factors underlying sensitivity of cancers to small-molecule kinase inhibitors. Nat Rev Drug Discov 8: 709-723, 2009.
52. Jia Z, Barford D, Flint AJ, and Tonks NK. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science 268: 1754-1758, 1995.
53. Julien S, Dubé N, Hardy S, and Tremblay M. Inside the human cancer tyrosine phosphatome. Nat Rev Cancer 11: 35-49, 2011.
54. Kalesh KA, Tan LP, Lu K, Gao L, Wang J, and Yao SQ. Peptide-based activity-based probes (ABPs) for targetspecific profiling of protein tyrosine phosphatases (PTPs). Chem Commun (Camb) 46: 589-591, 2010.
55. Kameshita I. In-gel phosphatase assay using fluorogenic and radioactive substrates. Curr Protoc Protein Sci Chapter 13:Unit13 12, 2011.
56. Kameshita I, Baba H, Umeda Y, and Sueyoshi N. In-gel protein phosphatase assay using fluorogenic substrates. Anal Biochem 400: 118-122, 2010.
57. Kameshita I, Ishida A, Okuno S, and Fujisawa H. Detection of protein phosphatase activities in sodium dodecyl sulfate-polyacrylamide gel using peptide substrates. Anal Biochem 245: 149-153, 1997.
58. Karisch R, Fernandez M, Taylor P, Virtanen C, St-Germain J, Jin L, et al. Global proteomic assessment of the classical protein-tyrosine phosphatome and "redoxome". Cell 146: 826-840, 2011.
59. Kawachi H, Fujikawa A, Maeda N, and Noda M. Identification of GIT1/Cat-1 as a substrate molecule of protein tyrosine phosphatase zeta/beta by the yeast substrate-trapping system. Proc Natl Acad Sci USA 98: 6593-6598, 2001.
60. Kinney CM, Chandrasekharan UM, Yang L, Shen J, Kinter M, McDermott MS, et al. Histone H3 as a novel substrate for MAP kinase phosphatase-1. Am J Physiol Cell Physiol 296: C242-C249, 2009.
61. Kolli S, Zito CI, Mossink MH, Wiemer EA, and Bennett AM. The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling. J Biol Chem 279: 29374-29385, 2004.
62. Kontaridis MI, Eminaga S, Fornaro M, Zito CI, Sordella R, Settleman J, et al. SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway. Mol Cell Biol 24: 5340-5352, 2004.
63. Krebs EG and Beavo JA. Phosphorylation-dephosphorylation of enzymes. Annu Rev Biochem 48: 923-959, 1979.
64. Krishnamurthy D and Barrios AM. Profiling protein tyrosine phosphatase activity with mechanistic probes. Curr Opin Chem Biol 13: 375-381, 2009.
65. Krishnan N, Fu C, Pappin D, and Tonks N. H2S-induced sulfhydration of PTP1B and its role in the endoplasmic reticulum stress response. Sci Signal 4: ra86, 2011.
66. Kumar S, Zhou B, Liang F,WangWQ, Huang Z, and Zhang ZY. Activity-based probes for protein tyrosine phosphatases. Proc Natl Acad Sci USA 101: 7943-7948, 2004.
67. Kumar S, Zhou B, Liang F, Yang H, Wang WQ, and Zhang ZY. Global analysis of protein tyrosine phosphatase activity with ultra-sensitive fluorescent probes. J Proteome Res 5: 1898-1905, 2006.
68. Kuo CC, Chu CY, Lin JJ, and Lo LC. Selective activation of SHP2 activity by cisplatin revealed by a novel chemical probe-based assay. Biochem Biophys Res Commun 391: 230-234, 2010.
69. Lee S-R, Yang K-S, Kwon J, Lee C, Jeong W, and Rhee S. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277: 20336-20342, 2002.
70. Leonard S, Garcia F, Goodsell D, and Carroll K. Redoxbased probes for protein tyrosine phosphatases. Angew Chem Int Ed 50: 4423-4427, 2011.
71. Li S, Wang H, Xian M, and Whorton A. Identification of protein nitrosothiols using phosphine-mediated selective reduction. Nitric Oxide 26: 20-26, 2012.
72. Liang F, Kumar S, and Zhang ZY. Proteomic approaches to studying protein tyrosine phosphatases. Mol Biosyst 3: 308-316, 2007.
73. Liu S, Zhou B, Yang H, He Y, Jiang ZX, Kumar S, et al. Aryl vinyl sulfonates and sulfones as active site-directed and mechanism-based probes for protein tyrosine phosphatases. J Am Chem Soc 130: 8251-8260, 2008.
74. Liu YK, Uemura T, Nemoto A, Yabe T, Fujii N, Ushida T, et al. Osteopontin involvement in integrin-mediated cell signaling and regulation of expression of alkaline phosphatase during early differentiation of UMR cells. FEBS Lett 420: 112-116, 1997.
75. Lo LC, Pang TL, Kuo CH, Chiang YL, Wang HY, and Lin JJ. Design and synthesis of class-selective activity probes for protein tyrosine phosphatases. J Proteome Res 1: 35-40, 2002.
76. Majeti R, Bilwes AM, Noel JP, Hunter T, and Weiss A. Dimerization-induced inhibition of receptor protein tyrosine phosphatase function through an inhibitory wedge. Science 279: 88-91, 1998.
77. Majeti R, Xu Z, Parslow TG, Olson JL, Daikh DI, Killeen N, et al. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103: 1059-1070, 2000.
78. Markova B, Gulati P, Herrlich PA, and Bohmer FD. Investigation of protein-tyrosine phosphatases by in-gel assays. Methods 35: 22-27, 2005.
79. McDermott U and Steeleman J. Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology. J Clin Oncol 27: 5650-5659, 2009.
80. Meinhart A, Silberzahn T, and Cramer P. The mRNA transcription/processing factor Ssu72 is a potential tyrosine phosphatase. J Biol Chem 278: 15917-15921, 2003.
81. Meng F and Zhang Z-Y. Redox regulation of protein tyrosine phosphatase activity by hydroxyl radical. Biochim Biophys Acta 1834: 464-469, 2013.
82. Meng T-C, Fukada T, and Tonks N. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-399, 2002.
83. Meng T-C, Hsu S-F, and Tonks N. Development of a modified in-gel assay to identify protein tyrosine phosphatases that are oxidized and inactivated in vivo. Methods 35: 28-36, 2005.
84. Merritt R, Hayman MJ, and Agazie YM. Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant. Biochim Biophys Acta 1763: 45-56, 2006.
85. Mikhailik A, Ford B, Keller J, Chen Y, Nassar N, and Carpino N. A phosphatase activity of Sts-1 contributes to the suppression of TCR signaling. Mol Cell 27: 486-497, 2007.
86. Milarski KL, Zhu G, Pearl CG, McNamara DJ, Dobrusin EM, MacLean D, et al. Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B. J Biol Chem 268: 23634-23639, 1993.
87. Mitra S and Barrios AM. Highly sensitive peptide-based probes for protein tyrosine phosphatase activity utilizing a fluorogenic mimic of phosphotyrosine. Bioorg Med Chem Lett 15: 5142-5145, 2005.
88. Montalibet J, Skorey KI, and Kennedy BP. Protein tyrosine phosphatase: enzymatic assays. Methods 35: 2-8, 2005.
89. Myers MP, Andersen JN, Cheng A, Tremblay ML, Horvath CM, Parisien JP, et al. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J Biol Chem 276: 47771-47774, 2001.
90. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95: 13513-13518, 1998.
91. Orsatti L, Innocenti F, Lo Surdo P, Talamo F, and Barbato G. Mass spectrometry study of PRL-3 phosphatase inactivation by disulfide bond formation and cysteine into glycine conversion. Rapid Commun Mass Spectrom 23: 2733-2740, 2008.
92. Palka HL, Park M, and Tonks NK. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J Biol Chem 278: 5728-5735, 2003.
93. Panchal RG, Ulrich RL, Bradfute SB, Lane D, Ruthel G, Kenny TA, et al. Reduced expression of CD45 proteintyrosine phosphatase provides protection against anthrax pathogenesis. J Biol Chem 284: 12874-12885, 2009.
94. Paul S, Olausson P, Venkitaramani DV, Ruchkina I, Moran TD, Tronson N, et al. The striatal-enriched protein tyrosine phosphatase gates long-term potentiation and fear memory in the lateral amygdala. Biol Psychiatry 61: 1049-1061, 2007.
95. Paulsen C, Truong T, Garcia F, Homann A, Gupta V, Leonard S, et al. Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity. Nat Chem Biol 8: 57-64, 2012.
96. Phillips RM, Bair E, Lawrence DS, Sims CE, and Allbritton NL. Measurement of protein tyrosine phosphatase activity in single cells by capillary electrophoresis. Anal Chem 85: 6136-6142, 2013.
97. Poole L, Karplus P, and Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 44: 325-347, 2004.
98. Rider D, Sinclair A, and Young S. Oxidative inactivation of CD45 protein tyrosine phosphatase may contribute to T lymphocyte disfunction in the elderly. Mech Ageing Dev 124: 191-198, 2003.
99. Rothman DM, Vazquez ME, Vogel EM, and Imperiali B. Caged phospho-amino acid building blocks for solid-phase peptide synthesis. J Org Chem 68: 6795-6798, 2003.
100. Salmeen A, Andersen J, Myers M, Meng T-C, Hinks J, Tonks N, et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423: 769-773, 2003.
101. Salmeen A, Andersen JN, Myers MP, Tonks NK, and Barford D. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell 6: 1401-1412, 2000.
102. Saurin A, Neubert H, Brennen J, and Eaton P. Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc Natl Acad Sci USA 101: 17982-17987, 2004.
103. Seth D and Rudolph J. Redox regulation of MAP kinase phosphatase 3. Biochemistry 45: 8476-8487, 2006.
104. Shen K, Qi L, Ravula M, and Klimaszewski K. Synthesis and peptide incorporation of an unnatural amino acid containing activity-based probe for protein tyrosine phosphatases. Bioorg Med Chem Lett 19: 3264-3267, 2009.
105. Skorey K, Waddleton D, Therien M, and Leriche T. Enzyme occupancy measurement of intracellular protein tyrosine phosphatase 1B using photoaffinity probes. Anal Biochem 349: 49-61, 2006.
106. Sohn J and Rudolph J. Catalytic and chemical competence of regulation of Cdc25 phosphatase by oxidation/reduction. Biochemistry 42: 10060-10070, 2003.
107. Stanford SM, Krishnamurthy D, Karver CE, Kulkarni RA, Bruenger E, Walker LM, et al. pCAP-based peptide substrates: the new tool in the box of tyrosine phosphatase assays. Methods 2013 [Epub ahead of print]; DOI: 10.1016/j.ymeth.2013.07.022.
108. Stanford SM, Panchal RG, Walker LM, Wu DJ, Falk MD, Mitra S, et al. High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45. Proc Natl Acad Sci USA 109: 13972-13977, 2012.
109. Stanford SM, Rapini N, and Bottini N. Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity. Immunology 137: 1-19, 2012.
110. Sun H, Charles CH, Lau LF, and Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487-493, 1993.
111. Sun H, Tan LP, Gao L, and Yao SQ. High-throughput screening of catalytically inactive mutants of protein tyrosine phosphatases (PTPs) in a phosphopeptide microarray. Chem Commun (Camb) 6: 677-679, 2009.
112. Sun J-P, Wang W-Q, Yang H, Liu S, Liang F, Federov A, et al. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation and tumor invasion. Biochemistry 44: 12009-12021, 2005.
113. Tabernero L, Aricescu AR, Jones EY, and Szedlacsek SE. Protein tyrosine phosphatases: structure-function relationships. FEBS J 275: 867-882, 2008.
114. Takakusa H, Kikuchi K, Urano Y, Kojima H, and Nagano T. A novel design method of ratiometric fluorescent probes based on fluorescence resonance energy transfer switching by spectral overlap integral. Chemistry 9: 1479-1485, 2003.
115. Tanner J, Parsons Z, Cummings A, Zhou H, and Gates K. Redox regulation of protein tyrosine phosphatases: structural and chemical aspects. Antioxid Redox Signal 15: 77-97, 2011.
116. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34: 148-150, 2003.
117. Therien M, Skorey K, Zamboni R, Li CS, Lau CK, LeRiche T, et al. Synthesis of a novel peptidic photoaffinity probe for the PTP-1B enzyme. Bioorg Med Chem Lett 14: 2319-2322, 2004.
118. Tiganis T and Bennett AM. Protein tyrosine phosphatase function: the substrate perspective. Biochem J 402: 1-15, 2007.
119. Tiganis T, Bennett AM, Ravichandran KS, and Tonks NK. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Biol 18: 1622-1634, 1998.
120. Timms JF, Carlberg K, Gu H, Chen H, Kamatkar S, Nadler MJ, et al. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages. Mol Cell Biol 18: 3838-3850, 1998.
121. Tiran Z, Peretz A, Attali B, and Elson A. Phosphorylationdependent regulation of Kv2.1 Channel activity at tyrosine 124 by Src and by protein-tyrosine phosphatase epsilon. J Biol Chem 278: 17509-17514, 2003.
122. Todd JL, Rigas JD, Rafty LA, and Denu JM. Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase ( JNK). Oncogene 21: 2573-2583, 2002.
123. Tolarová H, Dráberová L, Heneberg P, and Dráber P. Involvement of filamentous actin in setting the threshold for degranulation in mast cells. Eur J Biochem 34: 1627-1636, 2004.
124. Tonks NK. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121: 667-670, 2005.
125. Tonks NK. Protein tyrosine phosphatases-from housekeeping enzymes to master regulators of signal transduction. FEBS J 280: 346-378, 2013.
126. Tsuboi N, Utsunomiya T, Roberts RL, Ito H, Takahashi K, Noda M, et al. The tyrosine phosphatase CD148 interacts with the p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J 413: 193-200, 2008.
127. Tulsi NS, Downey AM, and Cairo CW. A protected lbromophosphonomethylphenylalanine amino acid derivative (BrPmp) for synthesis of irreversible protein tyrosine phosphatase inhibitors. Bioorg Med Chem 18: 8679-8686, 2010.
128. Uttamchandani M, Li J, Sun H, and Yao SQ. Activitybased protein profiling: new developments and directions in functional proteomics. ChemBioChem 9: 667-675, 2008.
129. van Montfort R, Congreve M, Tisi D, Carr R, and Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423: 773-777, 2003.
130. Veillette A, Rhee I, Souza C, and Davidson D. PEST family phosphatases in immunity, autoimmunity and autoinflammatory disorders. Immunol Rev 228: 312-324, 2009.
131. Wang Q, Scheigetz J, Roy B, Ramachandran C, and Gresser MJ. Novel caged fluorescein diphosphates as photoactivatable substrates for protein tyrosine phosphatases. Biochim Biophys Acta 1601: 19-28, 2002.
132. Wu J, Katrekar A, Honigberg LA, Smith AM, Conn MT, Tang J, et al. Identification of substrates of human proteintyrosine phosphatase PTPN22. J Biol Chem 281: 11002-11010, 2006.
133. Xie L, Zhang Y, and Zhang Z-Y. Design and characterization of an improved protein tyrosine phosphatase substrate-trapping mutant. Biochemistry 41: 4032-4039, 2002.
134. This reference has been deleted.
135. Yang J, Groen A, Lemeer S, Jans A, Slijper M, Roe S, et al. Reversible oxidation of the membrane distal domain of receptor PTPa is mediated by a cyclic sulfenamide. Biochemistry 46: 709-719, 2007.
136. Yu CL, Jin YJ, and Burakoff SJ. Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J Biol Chem 275: 599-604, 2000.
137. Yu X, Chen M, Zhang S, Yu ZH, Sun JP, Wang L, et al. Substrate specificity of lymphoid-specific tyrosine phosphatase (Lyp) and identification of Src kinase-associated protein of 55 kDa homolog (SKAP-HOM) as a Lyp substrate. J Biol Chem 286: 30526-30534, 2011.
138. Yudushkin IA, Schleifenbaum A, Kinkhabwala A, Neel BG, Schultz C, and Bastiaens PI. Live-cell imaging of enzyme-substrate interaction reveals spatial regulation of PTP1B. Science 315: 115-119, 2007.
139. Zhang S, Chen L, Luo Y, Gunawan A, Lawrence DS, and Zhang ZY. Acquisition of a potent and selective TC-PTP inhibitor via a stepwise fluorophore-tagged combinatorial synthesis and screening strategy. J Am Chem Soc 131: 13072-13079, 2009.
140. Zhang SH, Liu J, Kobayashi R, and Tonks NK. Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1. J Biol Chem 274: 17806-17812, 1999.
141. Zhang Y, Venkitaramani DV, Gladding CM, Zhang Y, Kurup P, Molnar E, et al. The tyrosine phosphatase STEP mediates AMPA receptor endocytosis after metabotropic glutamate receptor stimulation. J Neurosci 28: 10561-10566, 2008.
142. Zhang Y, Zhang M, and Zhang Y. Crystal structure of Ssu72, an essential eukaryotic phosphatase specific for the C-terminal domain of RNA polymerase II, in complex with a transition state analogue. Biochem J 434: 435-444, 2011.
143. Zhang Z-Y. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases. Acc Chem Res 36: 385-392, 2003.
144. Zhang Z-Y, Wang Y, and Dixon J. Dissecting the catalytic mechanism of the protein-tyrosine phosphatases. Proc Natl Acad Sci USA 91: 1624-1627, 1994.
145. Zhang ZY, Wang Y, Wu L, Fauman EB, Stuckey JA, Schubert HL, et al. The Cys(X)5Arg catalytic motif in phosphoester hydrolysis. Biochemistry 33: 15266-15270, 1994.